Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer, SCLC Chemoimmunotherapy

Heather Wakelee

MD

🏢Stanford University🌐USA

Professor and Chief

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Heather Wakelee at Stanford has contributed to lung cancer clinical research including contributions to IMpower133 establishing atezolizumab plus chemotherapy as first-line standard of care for extensive-stage small cell lung cancer — the first new first-line treatment to improve survival in SCLC in decades. Her contributions to both NSCLC and SCLC clinical trials represent important advances in thoracic oncology.

Share:

🧪Research Fields 研究领域

SCLC atezolizumab chemoimmunotherapy
IMpower133 SCLC
lung cancer clinical trials Stanford
NSCLC adjuvant immunotherapy
lung cancer KEYNOTE-091

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Heather Wakelee 的研究动态

Follow Heather Wakelee's research updates

留下邮箱,当我们发布与 Heather Wakelee(Stanford University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment